List of works - Konrad Kubiński

1,4-Naphthoquinone derivatives potently suppress Candida albicans growth, inhibit formation of hyphae and show no toxicity toward zebrafish embryos

scientific article published on 20 February 2018

A representative of arylcyanomethylenequinone oximes effectively inhibits growth and formation of hyphae in Candida albicans and influences the activity of protein kinases in vitro.

scientific article published on 5 December 2017

AD-O53.2--a novel recombinant fusion protein combining the activities of TRAIL/Apo2L and Smac/Diablo, overcomes resistance of human cancer cells to TRAIL/Apo2L.

scientific article published on 4 September 2014

Antifungal Agent 4-AN Changes the Genome-Wide Expression Profile, Downregulates Virulence-Associated Genes and Induces Necrosis in Candida albicans Cells

scientific article published on 25 June 2020

Benzimidazole inhibitors of protein kinase CK2 potently inhibit the activity of atypical protein kinase Rio1

scientific article published on December 2016

CX-4945: the protein kinase CK2 inhibitor and anti-cancer drug shows anti-fungal activity.

scientific article published on 13 May 2017

Catalytic activity of mutants of yeast protein kinase CK2alpha

scientific article

Different properties of four molecular forms of protein kinase CK2 from Saccharomyces cerevisiae.

scientific article published on 25 October 2005

Emodin, a natural inhibitor of protein kinase CK2, suppresses growth, hyphal development, and biofilm formation of Candida albicans.

scientific article

Fip1--an essential component of the Saccharomyces cerevisiae polyadenylation machinery is phosophorylated by protein kinase CK2.

scientific article

Human protein kinase CK2 phosphorylates matrix metalloproteinase 2 and inhibits its activity

scientific article

Inhibition of yeast ribosomal stalk phosphorylation by Cu-Zn superoxide dismutase

scientific article published on 01 September 2002

MSCs as Tumor-Specific Vectors for the Delivery of Anticancer Agents—A Potential Therapeutic Strategy in Cancer Diseases: Perspectives for Quinazoline Derivatives

scientific article published in 2022

New family of antimicrobial agents derived from 1,4-naphthoquinone

scientific article

New potent STS inhibitors based on fluorinated 4-(1-phenyl-1H-[1,2,3]triazol-4-yl)-phenyl sulfamates

scientific article published on 27 November 2019

New potent steroid sulphatase inhibitors based on 6-(1-phenyl-1<i>H</i>-1,2,3-triazol-4-yl)naphthalen-2-yl sulphamate derivatives

scientific article published on 01 December 2021

Novel 1,2,4-Oxadiazole Derivatives in Drug Discovery

scientific article published on 29 May 2020

Novel steroid sulfatase inhibitors based on N-thiophosphorylated 3-(4-aminophenyl)-coumarin-7-O-sulfamates

scientific article published on 13 July 2019

Phosphate and thiophosphate biphenyl analogs as steroid sulfatase inhibitors

scientific article published on 01 March 2015

Phosphorylation of thymidylate synthase from various sources by human protein kinase CK2 and its catalytic subunits

scientific article

Polysaccharide-Rich Fractions from Thunb.-Composition and Chemopreventive Potential

article

Steroid Sulfatase Inhibitors Based on Phosphate and Thiophosphate Flavone Analogs

scientific article published on 28 September 2015

Synthesis and Antimicrobial Activity of 4-Substituted 1,2,3-Triazole-Coumarin Derivatives

scientific article published on 18 January 2018

Synthesis and Biological Evaluation of Fluorinated 3-Phenylcoumarin-7-O-Sulfamate Derivatives as Steroid Sulfatase Inhibitors

scientific article published on 14 September 2015

Synthesis and biological evaluation of N-acylated tyramine sulfamates containing C-F bonds as steroid sulfatase inhibitors.

scientific article

Synthesis and biological evaluation of fluorinated N-benzoyl and N-phenylacetoyl derivatives of 3-(4-aminophenyl)-coumarin-7-O-sulfamate as steroid sulfatase inhibitors.

scientific article published on 22 January 2017

The Anti- Agent 4-AN Inhibits Multiple Protein Kinases

scientific article published on 02 January 2019

The Link between Protein Kinase CK2 and Atypical Kinase Rio1.

scientific article published on 7 February 2017

Yeast holoenzyme of protein kinase CK2 requires both beta and beta' regulatory subunits for its activity.

scientific article

Yeast surviving factor Svf1 as a new interacting partner, regulator and in vitro substrate of protein kinase CK2.

scientific article

List of works by Konrad Kubiński

1,4-Naphthoquinone derivatives potently suppress Candida albicans growth, inhibit formation of hyphae and show no toxicity toward zebrafish embryos

A representative of arylcyanomethylenequinone oximes effectively inhibits growth and formation of hyphae in Candida albicans and influences the activity of protein kinases in vitro.

AD-O53.2--a novel recombinant fusion protein combining the activities of TRAIL/Apo2L and Smac/Diablo, overcomes resistance of human cancer cells to TRAIL/Apo2L.

Antifungal Agent 4-AN Changes the Genome-Wide Expression Profile, Downregulates Virulence-Associated Genes and Induces Necrosis in Candida albicans Cells

Benzimidazole inhibitors of protein kinase CK2 potently inhibit the activity of atypical protein kinase Rio1

CX-4945: the protein kinase CK2 inhibitor and anti-cancer drug shows anti-fungal activity.

Catalytic activity of mutants of yeast protein kinase CK2alpha

Different properties of four molecular forms of protein kinase CK2 from Saccharomyces cerevisiae.

Emodin, a natural inhibitor of protein kinase CK2, suppresses growth, hyphal development, and biofilm formation of Candida albicans.

Fip1--an essential component of the Saccharomyces cerevisiae polyadenylation machinery is phosophorylated by protein kinase CK2.

Human protein kinase CK2 phosphorylates matrix metalloproteinase 2 and inhibits its activity

Inhibition of yeast ribosomal stalk phosphorylation by Cu-Zn superoxide dismutase

MSCs as Tumor-Specific Vectors for the Delivery of Anticancer Agents—A Potential Therapeutic Strategy in Cancer Diseases: Perspectives for Quinazoline Derivatives

New family of antimicrobial agents derived from 1,4-naphthoquinone

New potent STS inhibitors based on fluorinated 4-(1-phenyl-1H-[1,2,3]triazol-4-yl)-phenyl sulfamates

New potent steroid sulphatase inhibitors based on 6-(1-phenyl-1<i>H</i>-1,2,3-triazol-4-yl)naphthalen-2-yl sulphamate derivatives

Novel 1,2,4-Oxadiazole Derivatives in Drug Discovery

Novel steroid sulfatase inhibitors based on N-thiophosphorylated 3-(4-aminophenyl)-coumarin-7-O-sulfamates

Phosphate and thiophosphate biphenyl analogs as steroid sulfatase inhibitors

Phosphorylation of thymidylate synthase from various sources by human protein kinase CK2 and its catalytic subunits

Polysaccharide-Rich Fractions from Thunb.-Composition and Chemopreventive Potential

Steroid Sulfatase Inhibitors Based on Phosphate and Thiophosphate Flavone Analogs

Synthesis and Antimicrobial Activity of 4-Substituted 1,2,3-Triazole-Coumarin Derivatives

Synthesis and Biological Evaluation of Fluorinated 3-Phenylcoumarin-7-O-Sulfamate Derivatives as Steroid Sulfatase Inhibitors

Synthesis and biological evaluation of N-acylated tyramine sulfamates containing C-F bonds as steroid sulfatase inhibitors.

Synthesis and biological evaluation of fluorinated N-benzoyl and N-phenylacetoyl derivatives of 3-(4-aminophenyl)-coumarin-7-O-sulfamate as steroid sulfatase inhibitors.

The Anti- Agent 4-AN Inhibits Multiple Protein Kinases

The Link between Protein Kinase CK2 and Atypical Kinase Rio1.

Yeast holoenzyme of protein kinase CK2 requires both beta and beta' regulatory subunits for its activity.

Yeast surviving factor Svf1 as a new interacting partner, regulator and in vitro substrate of protein kinase CK2.